David Awotwe‐Otoo

434 total citations
9 papers, 346 citations indexed

About

David Awotwe‐Otoo is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pharmaceutical Science. According to data from OpenAlex, David Awotwe‐Otoo has authored 9 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pharmaceutical Science. Recurrent topics in David Awotwe‐Otoo's work include Protein purification and stability (7 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). David Awotwe‐Otoo is often cited by papers focused on Protein purification and stability (7 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). David Awotwe‐Otoo collaborates with scholars based in United States and Thailand. David Awotwe‐Otoo's co-authors include Mansoor A. Khan, Cyrus Agarabi, Rakhi B. Shah, Muhammad J. Habib, Sau Lee, Scott Lute, Kurt Brorson, Erik K. Read, Patrick J. Faustino and Ziyaur Rahman and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical and Biomedical Analysis and Biotechnology Progress.

In The Last Decade

David Awotwe‐Otoo

9 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Awotwe‐Otoo United States 9 181 80 61 57 49 9 346
Xichdao Nguyen United States 7 234 1.3× 49 0.6× 15 0.2× 34 0.6× 99 2.0× 7 349
Maciej Gajda Poland 11 84 0.5× 280 3.5× 27 0.4× 36 0.6× 42 0.9× 14 512
Jinghan Li United States 11 66 0.4× 96 1.2× 25 0.4× 38 0.7× 10 0.2× 23 271
Ruedeeporn Tantipolphan Netherlands 10 375 2.1× 47 0.6× 17 0.3× 29 0.5× 106 2.2× 10 510
Letha Chemmalil United States 10 347 1.9× 30 0.4× 46 0.8× 54 0.9× 124 2.5× 16 487
Bruno Lenain United States 3 133 0.7× 85 1.1× 143 2.3× 51 0.9× 10 0.2× 6 368
Nathaniel Milton United States 7 318 1.8× 130 1.6× 12 0.2× 40 0.7× 32 0.7× 7 439
N.A. Williams United States 11 154 0.9× 155 1.9× 15 0.2× 117 2.1× 23 0.5× 17 449
Ronald Fook Seng Lee Malaysia 11 114 0.6× 23 0.3× 23 0.4× 43 0.8× 14 0.3× 22 322
Khaled AboulFotouh Egypt 11 142 0.8× 164 2.0× 18 0.3× 25 0.4× 20 0.4× 16 367

Countries citing papers authored by David Awotwe‐Otoo

Since Specialization
Citations

This map shows the geographic impact of David Awotwe‐Otoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Awotwe‐Otoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Awotwe‐Otoo more than expected).

Fields of papers citing papers by David Awotwe‐Otoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Awotwe‐Otoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Awotwe‐Otoo. The network helps show where David Awotwe‐Otoo may publish in the future.

Co-authorship network of co-authors of David Awotwe‐Otoo

This figure shows the co-authorship network connecting the top 25 collaborators of David Awotwe‐Otoo. A scholar is included among the top collaborators of David Awotwe‐Otoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Awotwe‐Otoo. David Awotwe‐Otoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Agarabi, Cyrus, Scott Lute, Erik K. Read, et al.. (2016). Exploring the linkage between cell culture process parameters and downstream processing utilizing a plackett‐burman design for a model monoclonal antibody. Biotechnology Progress. 33(1). 163–170. 18 indexed citations
3.
Awotwe‐Otoo, David, Cyrus Agarabi, Erik K. Read, et al.. (2015). Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations. International Journal of Pharmaceutics. 490(1-2). 341–350. 14 indexed citations
4.
Siddiqui, Akhtar, Ziyaur Rahman, Saeed R. Khan, David Awotwe‐Otoo, & Mansoor A. Khan. (2014). Root cause evaluation of particulates in the lyophilized indomethacin sodium trihydrate plug for parenteral administration. International Journal of Pharmaceutics. 473(1-2). 545–551. 13 indexed citations
5.
Awotwe‐Otoo, David, Cyrus Agarabi, Erik K. Read, et al.. (2013). Impact of controlled ice nucleation on process performance and quality attributes of a lyophilized monoclonal antibody. International Journal of Pharmaceutics. 450(1-2). 70–78. 54 indexed citations
6.
Awotwe‐Otoo, David, Cyrus Agarabi, Patrick J. Faustino, et al.. (2012). Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate. Journal of Pharmaceutical and Biomedical Analysis. 62. 61–67. 119 indexed citations
7.
Awotwe‐Otoo, David, Cyrus Agarabi, David A. Keire, et al.. (2012). Physicochemical Characterization of Complex Drug Substances: Evaluation of Structural Similarities and Differences of Protamine Sulfate from Various Sources. The AAPS Journal. 14(3). 619–626. 22 indexed citations
8.
Awotwe‐Otoo, David, Ahmed S. Zidan, Ziyaur Rahman, & Muhammad J. Habib. (2012). Evaluation of Anticancer Drug-Loaded Nanoparticle Characteristics by Nondestructive Methodologies. AAPS PharmSciTech. 13(2). 611–622. 38 indexed citations
9.
Awotwe‐Otoo, David, Cyrus Agarabi, Elizabeth Casey, et al.. (2012). Quality by design: Impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody. International Journal of Pharmaceutics. 438(1-2). 167–175. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026